KORU Medical Systems Files 8-K on Financials

Ticker: KRMD · Form: 8-K · Filed: Jan 13, 2025 · CIK: 704440

Koru Medical Systems, Inc. 8-K Filing Summary
FieldDetail
CompanyKoru Medical Systems, Inc. (KRMD)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

KORU Medical Systems dropped an 8-K on Jan 13, 2025, with financial updates. Check it out.

AI Summary

KORU Medical Systems, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company, formerly known as REPRO MED SYSTEMS INC, is incorporated in Delaware and headquartered in Mahwah, NJ.

Why It Matters

This 8-K filing provides crucial updates on KORU Medical Systems' financial performance and operational status, which can influence investor decisions.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or unusual risks.

Key Players & Entities

  • KORU Medical Systems, Inc. (company) — Registrant
  • REPRO MED SYSTEMS INC (company) — Former company name
  • January 13, 2025 (date) — Date of report
  • Mahwah, NJ (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing for KORU Medical Systems, Inc.?

The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as provide Regulation FD Disclosures and Financial Statements and Exhibits.

When was this 8-K report filed?

This 8-K report was filed on January 13, 2025.

What was KORU Medical Systems, Inc. formerly known as?

KORU Medical Systems, Inc. was formerly known as REPRO MED SYSTEMS INC.

Where are KORU Medical Systems, Inc.'s principal executive offices located?

The principal executive offices are located at 100 Corporate Drive, Mahwah, NJ 07430.

Under which section of the Securities Exchange Act is this Current Report filed?

This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 831 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2025-01-13 09:21:18

Key Financial Figures

  • $0.01 — nge on which registered common stock, $0.01 par value KRMD The Nasdaq Stock Marke

Filing Documents

02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On January 13, 2025, KORU Medical Systems, Inc. (the "Company") issued a press release announcing certain preliminary financial results for the fiscal quarter and year ended December 31, 2024. The Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The preliminary financial results included in the press release are based on the Company's current estimate of its results for the fiscal quarter and year ended December 31, 2024, and remain subject to change based on the completion of closing and review procedures. The information contained in this Item 2.02 of the Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.

01. REGULATION FD DISCLOSURE

ITEM 7.01. REGULATION FD DISCLOSURE. On January 13, 2025, the Company posted an investor presentation, which may be accessed through the Company's investor relations website. A copy of the presentation is furnished herewith as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. The Company expects to use the investor presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others. The information contained in the investor presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission filings and other public announcements. The investor presentation speaks only as of the date of this Current Report on Form 8-K. The Company undertakes no duty or obligation to publicly update or revise this information, although it may do so from time to time. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or other public disclosure. The information contained in this Item 7.01 of the Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated January 13, 2025 99.2 Investor Presentation dated January 2025 104 Cover Page Interactive Data File (embedded within the inline XBRL document) - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORU Medical Systems, Inc. (Registrant) Date: January 13, 2025 By: /s/ Linda Tharby Linda Tharby President and Chief Executive Officer - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.